FREDUN PHARMACEUTICALS
Back to Balance Sheet
|
FREDUN PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹4.14 Cr | ₹3.84 Cr | ₹1.43 Cr | ₹1.38 Cr | ₹0.94 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of FREDUN PHARMACEUTICALS ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹4.14 Cr |
Mar2023 | ₹3.84 Cr |
Mar2022 | ₹1.43 Cr |
Mar2021 | ₹1.38 Cr |
Mar2020 | ₹0.94 Cr |
How is Deferred Tax Assets / Liabilities of FREDUN PHARMACEUTICALS Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹4.14 Cr | 7.65 | |
Mar2023 | ₹3.84 Cr | 168.55 | |
Mar2022 | ₹1.43 Cr | 3.92 | |
Mar2021 | ₹1.38 Cr | 46.33 | |
Mar2020 | ₹0.94 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of FREDUN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
FREDUN PHARMACEUTICALS | ₹457.8 Cr | 6.3% | 19.5% | 9.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,273.0 Cr | 2.5% | 4.1% | -0.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹176,604.0 Cr | 0.5% | -2.9% | 35.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹126,316.0 Cr | 6.2% | 9.3% | 17.9% | Stock Analytics | |
CIPLA | ₹125,993.0 Cr | 4.9% | 2.9% | 1.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,795.0 Cr | 2.1% | 1.2% | -5% | Stock Analytics |
FREDUN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
FREDUN PHARMACEUTICALS | 6.3% |
19.5% |
9.6% |
SENSEX | -1.5% |
-2.5% |
0.2% |
You may also like the below Video Courses